Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Aurora B/C kinase inhibitor GSK1070916A

(uh-ROR-uh … KY-nays in-HIH-bih-ter …)

A substance being studied in the treatment of some types of cancer. It blocks certain enzymes (Aurora kinases) involved in cell division and may kill cancer cells. It is a type of serine/threonine protein kinase inhibitor. Also called GSK1070916A.

Aurora B/C kinase inhibitor GSK1070916A

Search NCI's Dictionary of Cancer Terms